Skip to main content
Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
18.60
-1.49 (-7.42%)
At close: Apr 28, 2026, 4:00 PM EDT
18.25
-0.35 (-1.88%)
After-hours: Apr 28, 2026, 4:20 PM EDT

Aktis Oncology Revenue

In the year 2025, Aktis Oncology had annual revenue of $6.50M with 336.92% growth. Aktis Oncology had revenue of $1.87M in the quarter ending December 31, 2025.

Revenue (ttm)
$6.50M
Revenue Growth
+336.92%
P/S Ratio
158.25
Revenue / Employee
$82,241
Employees
79
Market Cap
1.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.50M5.01M336.92%
Dec 31, 20241.49M--
Dec 31, 2023---
Dec 31, 2022---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AKTS News

More News